Abstract
Scabies is an itchy skin disease caused by the burrowing mite Sarcoptes scabiei. During their lifespan, the female mites invade the stratum corneum and create tunnels, in which they reside, move, feed, deposit fecal pellets, and lay eggs. Recently, scabies was included in the World Health Organization roadmap for neglected tropical diseases 2021–2030. This review attempts to summarize our knowledge about the mite’s biology and the disease pathogenesis, pathological changes, and complications. Generally, the host–parasite interaction in scabies is highly complex and involves different mechanisms, some of which are yet largely unknown. Elucidation of the nature of such interaction as well as the underlying mechanisms could allow a better understanding of the mite’s biology and the development of novel diagnostic and therapeutic options for scabies control programs. Moreover, identification of the molecular basis of such interaction could unveil novel targets for acaricidal agents and vaccines.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Background
Scabies is a skin disease caused by a microscopic burrowing mite called Sarcoptes scabiei (S. scabiei). Recently, it was included in the world health organization (WHO) roadmap for the neglected tropical diseases (NTDs) 2021–2030, since it fulfills the recently specified WHO inclusion criteria for NTDs, being disproportionately influencing poor population, causing significant morbidity and mortality, mainly affecting people in tropics and subtropics, relatively neglected by researchers, and liable for control, elimination, or eradication (WHO 2020).
Regardless of the frequent reports indicating high prevalence, scabies is rarely prioritized in health control programs and research, possibly because disease complications span a wide range of disciplines such as parasitology, dermatology, immunology, infectious diseases, veterinary science, and disease ecology (Takano et al. 2023).
Epidemiology
Unfortunately, there are no available accurate current estimates regarding the global prevalence of scabies owing to the paucity of epidemiological data (Engelman et al. 2020). In the 2015 Global Burden of Disease Study, the global prevalence of scabies was estimated to affect more than 200 million individuals (Karimkhani et al. 2015). While scabies could affect people of all ages globally, children and the elderly in low-resource areas are the most vulnerable. The tropical countries have the highest prevalence for scabies. However, scabies is not confined to the tropical countries. Cold weather may be associated with increased incidence of scabies, which can be explained by increased direct personal contact and increased mites’ survival (Liu et al. 2016; El-Moamly 2021). Equally important, prolonged direct contact and overcrowding increase the risk of transmission and endemicity of scabies. So, scabies is an indirect reflection of poverty and overcrowding, rather than a disease of poor hygiene. This explains the high incidence of scabies in prisons, military camps, and boarding schools (Heukelbach et al. 2005; Alsamarai 2009).
Although both developing and developed countries are affected, scabies tends to be endemic in the resource-poor countries, with a higher morbidity and mortality. Sometimes, it can affect 20% or more of the whole population (Hay et al. 2012; Heukelbach et al. 2013). On the contrary, in the high-income countries, it usually occurs sporadically or in outbreaks in localities where people live in close quarters such as hospitals, nursing homes, prisons, childcare facilities and institutions for elderly (Ariza et al. 2012; Makigami et al. 2012).
Biology of Sarcoptes scabiei mite
Taxonomy and variants
Previously, Sarcoptes scabiei was known as Acarus scabiei, which was classified as a member of the genus Acarus. Later, it was placed in the genus Sarcoptes, which belongs to the superfamily Sarcoptoidea and the family Sarcoptidae (Arlian and Morgan 2017). Sarcoptes scabiei can be classified according to Schoch et al. (2020) as shown in (Table 1). Several variants of S. scabiei mites have been reported to infect humans and a wide range of mammals (e.g., S. scabiei var. canis for dogs, S. scabiei var. cuniculi for rabbits, S. scabiei var. vulpes for red fox and S. scabiei var. hominis for humans). Most authors suggest that genus Sarcoptes includes only one valid species with different varieties exhibiting different host-specific preferences (Arlian and Morgan 2017).
Morphology (Fig. 1)
Sarcoptes scabiei mite has a characteristic tortoise-like body. Its body shows the gnathosoma anteriorly, and the idiosoma posteriorly. The gnathosoma is a head-like structure, including the chelicerae and the pedipalps, that surround the mouth opening. The idiosoma is oval, ventrally flat, and dorsally arched, with four pairs of legs arising from the ventral aspect of the adult mites (Arlian and Morgan 2017). The dorsal surface of the idiosoma is not smooth. It shows transversely arranged ridges, scales, setae, and spines.
The female measures approximately 0.30–0.45 mm in length and 0.25–0.35 mm in width, while the male measures approximately 0.21–0.28 mm in length and 0.16–0.21 mm in width (Banzhaf et al. 2013). The eight legs of the adult mite are arranged in two sets, each set of them includes two pairs of legs which have similar morphology. Instead of the terminal bristle on the fourth leg, the male bears a sucker. This feature distinguishes males from females, and it appears to help the male mite during copulation in grabbing the female mite as these suckers are found near the genitalia (Klompen 1992).
Sarcoptes scabiei eggs are ovoid and measure about 0.10 to 0.15 mm in length. Identifying the unique morphological and biological features of the egg could help the researchers to understand why most available medications for scabies have little effect on this stage. The protective eggshell could be the first barrier that prevents current scabicides from reaching its target (Bernigaud et al. 2019).
The larva of the S. scabiei mite is the smallest ambulatory stage of the mite (about 200 µm long and 155 µm wide) that immediately hatches from the egg. It has only six legs. The nymph is the largest immature stage just prior to the final molt. It is smaller than the adult female and about the same size as the adult male (Arlian and Morgan 2017).
Life cycle
Sarcoptes scabiei has five developmental stages in its life cycle: egg, larva, protonymph, tritonymph, and adult. Adults mate on the skin of the host, and males search the skin for the unfertilized females for several days after mating. During their lifespan, which is about 4–6 weeks, the females lay 2–4 eggs per day in a burrow in the stratum corneum. Two to four days after the egg has been laid, a larva with sex legs emerges. The larva digs a new pocket burrow to leave the burrow. It wanders on the surface of the host's body for 14–17 days till maturation. Maturation occurs as the larva moults into the eight-legged protonymph, tritonymph, and then the adult male or female (Kraabol et al. 2015).
Survival, infectivity, and transmission between different hosts
Prolonged direct contact, including sexual contact, with a host infected by S. scabiei mite is generally considered to be the main mode of transmission of scabies. However, the host-seeking behavior of the mite could allow indirect transmission via fomites like bed linens, towels, and clothes also (Walton and Currie 2007).
The indirect transmission is largely affected by the ability of the mite to survive and to remain infective while off the host in the external environment, which in turn is affected by the environmental temperature and relative humidity. Higher temperatures (even at high humidity) are associated with shorter survival time of the mite. In these conditions, S. scabiei mite usually dies due to its inability to maintain water balance in its body. In contrast, higher relative humidities and lower temperatures allow longer survival time for the mite. Generally, all life stages could survive for one to nine days at 15–25° C and 25- 97% relative humidity (Arlian and Morgan 2017).
Regarding infectivity, experiments show that scabies mite could keep its infectivity for at least one half to two thirds of its survival time in the external environment off its host. For example, at room conditions, S. scabiei var. suis was found to remain infective for about 24 h after death of its host (pig). Along similar lines, S. scabiei var. canis retain its ability to infect new hosts for about 36 h after death of its host (Alasaad et al. 2013).
Skin penetration, feeding and water balance maintenance
When S. scabiei infects a host, it starts secreting saliva that forms a pool around their body to lyse the stratum corneum of the epidermis. As the mite sinks into the stratum corneum, the anterior two pairs of legs move in a tortoise-like pattern (i.e., swimming motion) to advance forward within the tunnel. The mite imbibes its water needs from the host intercellular fluid (lymph) that leaks into the burrow around the mite mouthparts when they burrow deep in the stratum corneum near the lower living epidermal layers (Arlian and Morgan 2017). Detection of the host’s IgG antibody in freshly separated mites’ midgut is clear evidence that mites consume the serum of the host (Rapp et al. 2006).
Host immune response to Sarcoptes scabiei
Within the epidermis, the first functional immune cells to be stimulated by the scabies mite and its products are keratinocytes, dendritic cells, and Langerhans cells (LCs) (Bhat et al. 2017). When the mite’s products reach the dermis, they stimulate fibroblasts, microvasculature endothelial cells, and immunological effector cells such as LCs, macrophages, mast cells, and lymphocytes. The antigens from the mites in the skin are likely taken up and processed by the LCs and other dendritic cells, which then transport them to the regional lymphatic tissue, where B- and T-lymphocytes are activated, triggering an adaptive immune response (Walton 2010).
Innate immune response
Innate immune cells
Dermal infiltration with eosinophils is an integral part of the host immune response to S. scabiei, especially in CS, possibly due to the high expression of interleukin-5 (IL-5). The recruitment, activation, and maturation of eosinophils are all aided by IL-5. Even peripheral eosinophilia has been reported in CS (Roberts et al. 2005; Jayaraj et al. 2011; Bhat et al. 2017).
The exact role of eosinophils in ordinary scabies (OS) and CS is still unknown. They may control the T helper-2 (Th2) response through expressing some Th2 cytokines (Walton et al. 2010). Also, they may influence the Th1 response through synthesis of IL-12 and interferon gamma (IFN-γ), as well as expression of many toll-like receptors (TLRs) as TLR-7 (Nagase et al. 2003). Furthermore, the eosinophil expression of IL-10 and transforming growth factor beta (TGF-β) may reduce the local inflammatory responses by influencing the activity and growth of regulatory T cells (Jacobsen et al. 2007).
The dermal infiltration with mast cells and basophils has been reported in scabies, especially in CS. Upon activation, they produce tumor necrosis factor alpha (TNF-α), IL-6, and Th2 cytokines, including IL-4, IL-5 and IL-13 (i.e., main cytokines in allergic Th2 response) (Prussin and Metcalfe 2006; Schroeder 2011).
Macrophages, neutrophils and dendritic cells are immune effector cells involved in phagocytosis, antigen presentation, differentiation of T-cells, and proinflammatory responses. Various degrees of dermal infiltration by these cells have been reported in scabies. Their exact roles in the immune and inflammatory responses in scabies need further investigations (Bhat et al. 2017).
Complement system
The detection of C3a and C4a in skin biopsies from affected hosts may imply that complement system is involved in the immune response to the scabies mites (Roberts et al. 2005; Walton et al. 2008). Surprisingly, low serum C3, C4, or both have been reported in CS, suggesting a potential defect in the complement function, or system failure due to massive overload of mites and bacteria. Both C3a and C5a can activate mast cells, leading to release of the inflammatory mediators such as histamine and TNF-α (Roberts et al. 2005).
Adaptive immune responses
According to the type and magnitude of the elicited immune response, two major forms of scabies are recognized: OS and crusted scabies (CS) (Walton and Oprescu 2013). Ordinary scabies has been proved to be associated with a protective local immune response that is dominated by cluster of differentiation (CD) 4 + T-lymphocytes with a Th1 cytokine profile (i.e., IFN-γ, TNF-α and IL-2) (Liu et al. 2014). In contrast, the immune response in CS has been proved to be dominated by CD8 + T-lymphocytes, with a non-protective Th2 cytokine profile (i.e., IL-4, IL-5 and IL-13) (Walton et al. 2008; Liu et al. 2014). Th17 cells are another major subset of T-cells that share in the local immune response in cases of CS by recruiting and activating neutrophils at sites of inflammation. Also, they stimulate endothelial cells, keratinocytes, and fibroblasts to produce inflammatory cytokines, like IL-1, IL-6, and TNF-α. Their role in CS is evidenced by high levels of IL-17 and IL-23 (Bhat et al. 2017).
Regulatory T-lymphocytes (Treg) also may have a role in the control or development of scabies. They may inhibit the inflammatory and immune reactions to the parasite via secretion of IL-10 and inhibition of synthesis of the proinflammatory cytokines like TNF-α, IFN-γ and IL-2 (Liu et al. 2014). This may partially explain the incubation period in a primary infestation by S. scabiei. There is a negative correlation between activity of Treg cells and severity of lesions in scabies (Abd El-Aal et al. 2016). This explains why skin pathology is severe in CS, in which IL-10 production is significantly reduced, compared to OS, leading to expansion of Th17 cells and a Treg/Th17 dysfunctional immune response (Gonzalez-Lombana et al. 2013).
Infestation with S. scabiei mites could trigger strong antibody-mediated immune responses, particularly in CS, which has extremely high levels of antigen-specific IgG and IgE when compared with OS. This difference could be explained by the high expression of IL-4 and IL-13 in CS. Interleukin-4 and IL-13 play crucial roles in B cell class switching and induction of IgE and IgG4 co-expression. Unfortunately, timing of the antibody-mediated immune responses, as well as their relative importance in establishing protective immunity, are still largely unknown (Bhat et al. 2017).
Pathogenesis of scabies (Fig. 2)
Histopathological changes in crusted scabies. Note the pigtails sign which represents the empty eggshells “yellow arrow”, heavy mite infestation “yellow dashed circles”, rete ridges hypertrophy “red arrows”, sebaceous glands hypertrophy “yellow arrowhead”, and diffuse heavy dermal inflammatory infiltration (Hematoxylin and eosin, × 100)
The host–parasite interaction in scabies is highly complex and involves different interconnected factors, some of which are yet largely unknown, and it is not easy to distinguish the contribution of each factor separately. Generally, scabies pathogenesis could be summarized as follows:
Triggering the cascading pathogenic consequences by S. scabiei
The mites invade the stratum corneum of the epidermis and create tunnels, in which they reside, move, feed, deposit fecal pellets and lay eggs. Using the cutting mouthparts and hooks on their legs, the mites burrow deeply in the stratum corneum near the lower living epidermal layers. To facilitate burrowing and feeding, mites release substances that may aid in lysis of the host tissue (Bornstein et al. 2001; Pence and Ueckermann 2002). Being close enough to the lymph in their residence in the epidermis, the lymph could flow into the burrow and supply the mites with nutrients and water needs. The soluble mite antigens, released from both viable and dead mites, can then diffuse into the dermis, triggering an immunological and inflammatory response in the host (Arlian and Morgan 2017). The role of dead mites in the pathogenesis of scabies explains why pruritus persists for some time after treating scabies (Zhu et al. 2004; Elder et al. 2009).
Immunopathogenesis
The main manifestations of scabies are mediated through the inflammatory and allergic responses mounted by the host against the mite products that are deposited under the skin. Both immediate (type I) and delayed (DTH or type IV) hypersensitivity responses are involved (Walton et al. 2008; Bhat et al. 2017). Although the exact role of cell-mediated and humoral host immune responses in the pathogenesis of OS and CS remains largely unknown, it is now well established that clinical severity of the disease depends on variations in the type and amplitude of the associated cellular and humoral responses (Gazi et al. 2022).
The presence of T lymphocytes in the locally evoked immune response against S. scabiei is an integral feature that generally indicates development of DTH reaction, which could be elicited by either CD4 + or CD8 + T-cells. They release mediators that stimulate local endothelial cells and enhance recruitment of inflammatory cells, causing lesion development (Yalew 2020; Doukas et al. 2021). Like atopic dermatitis, the dermal lymphocytic infiltrate in OS is dominated by CD4 + T-cells, with a reported CD4/CD8 ratio of 4:1. In contrast, CD8 + T-cells dominate the dermal lymphocytic infiltration in CS, with minimal or no CD4 + T-cells. Similar findings have been reported in psoriasis, a disease characterized by erythematous scaly papules, plaques, and abnormal keratinocyte hyperproliferation (Walton et al. 2008; Bhat et al. 2020).
Although the exact role of CD8 + T cells in CS is unspecified, they may induce tissue damage by exhibiting direct cytotoxicity against keratinocytes and/or releasing cytokines, which could enhance the inflammatory response targeting resident skin cells (Hay et al. 2012; Bhat et al. 2017; Gazi et al. 2022). Th17 cells are another major subset of T-cells that share in the pathogenesis of CS by recruiting and activating neutrophils at sites of inflammation. Also, they stimulate endothelial and epithelial cells to produce inflammatory cytokines, like IL-1, IL-6, and TNF-α (Bhat et al. 2017).
Since it has been described as one of the most prominent cytokines in CS skin lesions, interleukin-1β (IL-1β) appears to be a crucial cytokine in the pathogenesis of CS. It is involved in the differentiation and activation of T lymphocytes, including Th17. Furthermore, it has been reported to have a synergistic effect with TNF-α, thus triggering the inflammatory cascade by IL-1β and TNF-α could result in inflammation, tissue damage, and loss of function (Walton et al. 2008; Bhat et al. 2020). Interestingly, IL-1β has also been incriminated to be a key player in the pathogenesis of psoriasis (Cai et al. 2019).
Transforming growth factor-β, IL-4, IL-10 and IL-13 are among cytokines implicated in the pathogenesis of CS. They inhibit macrophage activation. Also, TGF-β could suppress the inflammatory Th1 response. Failure to evoke an effective immune response could explain the extensive numbers of mites over the body of the host. Along similar lines, IL-4 could trigger keratinocytes proliferation, since epidermal cells have IL-4 receptors. Interestingly, IL-4R expression has been reported to be upregulated in psoriasis. IL-4 could also contribute to the excessive IgE synthesis observed in CS (Walton 2010; Hashim et al. 2020).
Although S. scabiei can elicit a strong humoral immune response in CS, antibodies do not appear to be protective in scabies. Specific IgE, on the other hand, plays a significant role in the pathogenesis of allergic diseases (Abd El-Aal et al. 2016). Notably, IgE response is frequently accompanied by IgG4 production. The precise functions of IgG4 in scabies are still questionable, however it may protect the host against anaphylactic reactions by serving as blocking antibodies (i.e., block IgE receptor sites on antigens) (Walton et al. 2010; Scott-Taylor et al. 2018).
Despite the high serum levels of IgE, IgG, and IgG subclasses in CS, B lymphocytes are typically absent in dermal inflammatory infiltrate. This may be a contributing factor that explains the failure of the locally evoked immune response to protect the host against the mites. Furthermore, skin does not contribute to the high levels of serum immunoglobulins in CS (Doukas et al. 2021). In contrast to CS, B-cell infiltration and activation have been described in OS skin lesions, with deposition of IgM and IgA at the dermal–epidermal junction. Furthermore, C3 deposition within dermal blood vessels has been described. Hence, local inflammatory responses in OS skin lesions could be mediated through deposition of S. scabiei-specific antigen–antibody complexes and complement activation (Walton et al. 2008).
Scabies has traditionally been referred to as "the worst itch" a patient could ever experience, highlighting the excruciating itching that occurs in this disease. Such itching can be caused by either the scabies mite's direct action or the host immune response to it. Sarcoptes scabiei can trigger itching through activation of TLR-3,4 and 7 expressed on primary sensory neurons (Taves and Ji 2015). Furthermore, proteases present in mite feces could stimulate protease-activated receptor-2 (PAR-2), a known pruritic receptor, on keratinocytes (Lavery et al. 2016).
Moreover, itching may be induced by the immune response developed by the host against the mite through different possible mechanisms. The first mechanism involves complement system activation, which in turn activates mast cells, causing release of histamine, tryptase, and TNF-alpha (Ricklin et al. 2010; Misery 2014). The second mechanism involves activation of macrophages, resulting in production of prostaglandins and leukotrienes that potentiate the itch. Furthermore, the Th1 response in classic scabies is associated with production of IFN- γ, TNF- α, and IL-2 that activate pruriceptors, whereas the Th2 response in CS is associated with activation of pruriceptors via B-cell activation, production of IL-4, IL-5, IL-13, and IL-31, and IgE-mediated mast cell activation (Misery 2014; Kim et al. 2021).
Modulation of the host inflammatory and immune responses by S. scabiei
Tissue-feeding parasites, like S. scabiei, confront significant threats that endanger their early survival, being exposed to the host’s immune mechanisms both internally (by the ingested epidermal proteins and plasma) and externally. As a result of a long co-evolution with its mammalian hosts, the mite has evolved several mechanisms to evade the host's innate and adaptive immune responses (Hay et al. 2012).
Although hosts exhibit different immune mechanisms to fight the mite, as mentioned above, clinical symptoms of a primary S. scabiei infestation can take up to four to eight weeks to appear (Morgan et al. 2013). Evidence suggests that the mites produce chemicals that inhibit the host's early inflammatory and immune responses. This delay is thought to give the mite population time to establish in the host before a strong defense response is elicited. Inflammatory and immune reactions, on the other hand, appear more rapidly in sensitized hosts (Elder et al. 2009).
Live scabies mites have been reported to trigger cells in human skin equivalents, like fibroblasts and keratinocytes, to secrete the anti-inflammatory cytokine interleukin-1 receptor antagonist (IL-1ra). By binding to the IL-1 receptor, which is located on numerous cells including T-cells, B-cells, natural killer cells, macrophages, and neutrophils, IL-1ra inhibits the function of the proinflammatory cytokine IL-1 (Morgan and Arlian 2010).
Along similar lines, S. scabiei mite extract has been reported to inhibit the production of intercellular and vascular cell adhesion molecules as well as E-selectin in cultured normal human endothelial cells of the skin microvasculature. As a result, extravasation of lymphocytes, neutrophils, and other cells into the dermis would be inhibited or diminished. Consequently, the host's capacity to evoke a successful protective response would be hampered (Elder et al. 2006).
Human T-regulatory cells have been reported to be stimulated to generate IL-10 by scabies mite extract. By decreasing the release of proinflammatory cytokines and the expression of MHC-II molecules on antigen-presenting cells, IL-10 serves as a strong anti-inflammatory cytokine. Thus, the connection between the MHC-II-antigen complex and the T-cell receptor, which is required for B-cell activation and proliferation into antibody-secreting plasma cells, would be inhibited/reduced (Arlian et al 2006).
In response to live scabies mites and mite extracts, human skin equivalents and monocultures of normal human epidermal keratinocytes and dermal fibroblasts have been reported to increase production of vascular endothelial growth factor. The vascular endothelial growth factor would enhance vascularity and fluid (plasma) entry to the mite burrow around the mite's mouthparts. This fluid is the mite's primary source of water and nutrients in the otherwise dry stratum corneum (Arlian et al. 2003; Morgan and Arlian 2010).
Interference with IL-8 activity is another mechanism by which the mite can modulate immune response of the host. Interlukin-8 is a chemokine that is chemotactic for neutrophil extravasation to the location of a pathogen (Mullins et al. 2009). When compared to unchallenged controls, monocultures of human epidermal keratinocytes, dermal fibroblasts, microvascular endothelial cells of the skin, and dendritic cells challenged with scabies extract showed lower levels of IL-8 in the medium (Arlian et al. 2003, 2004; Elder et al. 2006). Furthermore, scabies mites can produce IL-8 binding protein that reduces local IL-8 levels, hence limiting neutrophil chemotaxis (Mullins et al. 2009).
Sarcoptes scabiei have been reported to use gut serine protease inhibitors to bind to many plasma proteins involved in the complement activation pathways and block the three pathways of the human complement system (classical, alternative, and lectin). Since mites consume plasma, inactivating host complement may protect the mite gut from complement-mediated damage (Rapp et al. 2006). Complement suppression may enhance the pyoderma produced by group A streptococci, which is frequently linked with scabies lesions (Mika et al. 2012a, b).
Sarcoptes scabiei and secondary bacterial infections
Hosts infected with S. scabiei are often particularly susceptible to 2ry bacterial infection, being undernourished and immunologically disarmed. As a result, complications like cellulitis, lymphangitis and acute glomerulonephritis could occur. Death may occur in severe cases (Kemp et al. 2002). In humans, Staphylococcus aureus and group A haemolytic streptococci are the most common examples reported in scabies (Brook 2002). Interestingly, they have been isolated from skin burrows as well as mite fecal pellets, suggesting that scabies mites may aid in the transmission of pathogenic bacteria within the host (McCarthy et al. 2004).
Sarcoptes scabiei and oxidative stress
Free radicals form an integral part in the host's defense against the parasites, but when they are produced in large quantities, the antioxidant mechanisms become overwhelmed, and the generated free radicals can then interact with endogenous macromolecules, resulting in damage to DNA, lipids, and proteins, as well as inducing and/or enhancing tissue injury (Pizzino et al. 2017). The proinflammatory cytokines induced by S. scabiei, including IL-1, IL-6, IL-17, TNF-α and IFN- γ, can lead to excessive generation of free radicals. Recent findings suggest that oxidative stress-induced tissue damage plays an important role in the pathogenesis of many skin disorders. Free radicals can then induce or aggravate skin lesions in scabies such as erythema, inflammation, and abnormal keratinization (Bickers and Athar 2006). Recently, S. scabiei has been reported to cause oxidative stress in mammalian hosts (Abu Hafsa et al. 2021; Sharaf et al. 2023a).
Histopathological changes in scabies
Local changes
While there is a considerable histopathologic overlap between different clinical forms of scabies, there are some characteristics that are more distinctive to each (Elwood et al. 2015).
Ordinary scabies
Macroscopically, lesions usually appear within four to eight weeks after primary infestation by S. scabiei. However, they can appear as soon as one to two days in case of secondary infestation (McCarthy et al. 2004). The burrow is the pathognomonic lesion for scabies. It is a short, straight track that ends in an intact vesicle or erosion harboring the mite. It is usually found in the web spaces of the fingers, hands, wrists, axillae, feet, buttocks, and genitalia. Although the presence of burrows is pathognomonic for scabies, they are only seen in a few cases. Instead, nonspecific secondary lesions such as excoriated papules, eczematous or lichenified plaques, nodules are more commonly seen (Cassell et al. 2018).
Microscopically, the ordinary type is typically characterized by irregular acanthosis, spongiosis and exocytosis of eosinophils and neutrophils. Occasionally, intraepidermal microabscesses are formed. Older lesions may show parakeratosis and signs of excoriation such as serum crusts (Hicks and Elston 2009). Deeply within the stratum corneum of the epidermis, burrows containing adult females, eggs, eggshells, larvae and/or fecal deposits could be seen.
Adult female could be identified by its characteristic oval body with thin exoskeleton and dorsal spines (Mathison and Pritt 2014). Even in cases in which the entire mite is not visible, curled pink structures that have been referred to 'pigtails' are a very valuable clue in the stratum corneum. These structures are the remains of eggs that have been left behind after hatching (Cardoso et al. 2017).
Regarding dermal changes, superficial or deep perivascular and interstitial mixed inflammatory cell infiltration, including lymphocytes, histiocytes, and eosinophils, is commonly seen (Hengge et al. 2006). Although vascular changes are not common, endothelial swelling, luminal narrowing, vasculitis and fibrinoid deposition within and around vessels may occur (Elwood et al. 2015).
Nodular scabies
This type of scabies may develop in patients with chronic infestation, probably due to hypersensitivity. Macroscopically, it is characterized by severe eczematous changes and highly pruritic nodules, especially on male genitalia and breasts, that persist for weeks or months even after effective treatment (Sil et al. 2020). Microscopically, nodular scabies is characterized by dense perivascular inflammatory infiltrations with lymphocytes, histiocytes, eosinophils, plasma cells, and occasionally atypical mononuclear cells with mitoses. The epidermal changes are less frequent than those seen in OS, but focal spongiosis and microabscesses may occasionally occur. Moreover, vasculitis with fibrinoid degradation of dermal vessel walls is more frequent in nodular scabies.
Lesions of nodular scabies were previously regarded to be an exaggerated hypersensitivity reaction to the mite and its products, rather than by an active infestation, because mites were rarely found by the mineral oil test or routine skin biopsy (Mittal et al., 1997). However, Suh et al. (2014) suggested a need to differentiate nodular scabies with active infestation from that without active infestation. The authors stated that high-frequency detection of mites in nodular scabies was thought to be associated with the use of dermoscopy, which identified the specific findings of scabies and allowed determination of the proper site for biopsy. Dermoscopic findings such as “delta wing jet” sign (the appearance of a brown triangle that corresponds to the head and the two anterior pairs of legs of the mite) or “jet with contrail” (the appearance of a brown triangle in addition to the white S-shaped burrows which are filled with eggs and scybalas) are considered to be features specific to scabies (Micali et al. 2016).
Bullous scabies
It is a rare variety of scabies that usually affect elderly males. Macroscopically, lesions usually mimic those of bullous pemphigoid and manifest as highly irritating bullae that could be flaccid or tense, with or without the classic signs of scabies. Several mechanisms have been proposed to explain bullae formation in scabies. Like bullous impetigo, bullous scabies can result from secondary infection of the scabietic lesions with Staphylococcus aureus (Luo et al. 2016). Although bullous scabies may resemble bullous impetigo, presence of mites, eggs, or scybala on direct microscopy or histological sections is diagnostic (Salame and Holland 2019).
In some cases, lesions are associated with anti-basement membrane zone (BMZ) autoantibodies, which are consistent with the diagnosis of bullous pemphigoid. Sarcoptes scabiei mites are thought to produce certain enzymes and bullous pemphigoid-like antigens, a phenomenon of antigen mimicry, that induce BMZ antibodies formation, causing complement cascade activation, dermo-epidermal separation and BMZ lytic destruction. The presence of mites within the bullae could support this hypothesis (Kokubu et al. 2019).
Crusted scabies
Macroscopically, CS is characterized by formation of yellowish-brown, yellowish-green, or gray crusts that are firmly adherent to the underlying tissues and have a porous appearance when removed. There might be fissuring over the extensor surface of joints. Itching is minimal or even absent (Walton et al. 2010). Crusts are typically seen on the scalp, ear, extensor aspect of elbows, and soles. Nails, like psoriatic nails, exhibit subungual hyperkeratosis and are a major source of relapse (Last et al. 2018). It can occasionally manifest as erythroderma, psoriasis, eczema, seborrheic dermatitis, and pityriasis rubra pilaris (Roberts et al. 2005). However, the diagnosis can be confirmed by microscopic examination of skin scrapings. Davis et al. (2013) developed a grading system for CS based on distribution and extent of crusts, history of previous attacks, and skin condition. The grades were classified as mild (grade 1, score 4–6), moderate (grade 2, score 7–9), or severe (grade 3, score 10–12) (Table 2).
Microscopically, CS is characterized by marked orthokeratotic hyperkeratosis, parakeratosis, irregular acanthosis, and stratum basale hyperplasia. Sebaceous glands and hair follicles are usually hyperplastic, blocked, and inflamed. The epidermis has many burrows in which numerous mites, eggs, larvae, and fecal pellets reside. Also, serum crusts and extravasated erythrocytes are frequent findings. The dermis usually shows superficial and deep perivascular lymphohistiocytic infiltrates with many eosinophils, plasma cells and neutrophils (Sharaf et al. 2023b) (Fig. 3).
Infantile scabies
Because of their weak pincer grip and inability to scratch properly, infants with scabies usually have few excoriations, and many burrows. Burrows often show signs of inflammation and are associated with papulovesicular and nodular lesions. Pustules and hemorrhagic crusts may also occur (Hill and Cohen 2017). The mite burden is greater than that in classic scabies in older patients, with several hundred mites found in one patient. In addition, as compared to older children and adults who show with widely disseminated lesions, the early eruption in infants is frequently localized.
Infants have been reported to have more nodules and lower limb involvement, particularly of the soles, than older children and adults with scabies. However, involvement of the scalp and face is also common (Karthikeyan 2007; Boralevi et al. 2014; Eshagh et al. 2014). Inadequate diagnosis might result in superficial skin infections, ecthyma, and cellulitis. Infantile scabies should be distinguished from other similar diseases that may manifest at this age, such as papular urticaria, atopic dermatitis, and infantile acropustulosis (Hill and Cohen 2017).
Scabies in elderly
Burrows on the soles of the feet are more common in elderly patients. The finger webs may be completely spared. In contrast to the younger population, scalp and face involvement is common (Berger and Steinhoff 2011). Old patients are more likely to get CS due to various factors in this age group, such as altered immune response, nutritional deficiencies, cognitive disturbances, and inability to maintain personal hygiene (Anderson and Strowd 2017).
Scabies incognito
When topical or systemic corticosteroids are used to treat scabies, they obscure the typical itching and inflammation. These cases commonly occur in patients with good hygiene and are referred to as scabies incognito. In such cases, the diagnosis might be readily confused with other skin conditions (Yoshinaga et al. 2009). Although symptoms are masked, the patient remains infectious to others. It is critical to get an accurate diagnosis of scabies incognito since misdiagnosis could lead to dangerous effects such as lesion spreading and superinfection, which can occasionally be fatal (Herwanto et al. 2019).
Animal scabies
Occasional cases of scabies have been reported following prolonged human exposure to mangy animals. However, patients usually present with a totally different picture from that which is produced by the S. scabiei var hominis infection. Because each strain of the mite usually prefers one type of host and does not survive for a long time or reproduce away from it, humans are unlikely to get full-blown scabies from this animal source. In most cases, the infection is self-limiting, with a short incubation period and transient symptoms. As a result, if a patient is suspected to have animal scabies, no treatment of the patient's human contacts is required (Walton and Currie 2007).
Since these regions are exposed to S. scabiei mites when the affected animals are carried, lesions are usually found on forearm, lower chest, abdomen, and thighs. Interestingly, both interdigital spaces and genitalia are usually spared. Furthermore, the characteristic deep and long burrows are not formed. Instead, mites burrow into the skin to lay eggs for a short time, inducing itching and severe irritation. Secondary bacterial infection may occur, leading to complications like acute post streptococcal glomerulonephritis (Bandi and Saikumar 2013).
Systemic changes
Despite the availability of wide-ranging data on the local pathological changes in scabies, there are still few studies that address the pathological changes that occur in the non-dermal organs. In a recent study performed on severely affected mangy New Zealand rabbits, Sharaf et al. (2023a) reported definite structural changes observed at the systemic level, evidenced by histopathological changes (severe congestion, different forms of degenerative changes, and inflammatory infiltration) in hepatic, renal, cardiac, and splenic tissue samples (Fig. 4).
Photomicrographs of tissue sections from internal organs of rabbits with crusted scabies. Figures (A, B, and C) represent liver sections and show marked hepatic congestion "yellow arrows"(A, B), various degrees of degenerative changes as hydropic degeneration "yellow arrowhead" and pyknotic nuclei of hepatocytes "black arrow" (B), and mild to moderate periportal inflammation and fibrosis "red arrows" (C). Figures (D, E, and F) represent renal sections and show severe renal congestion "red arrow", thick-walled renal vessels "black arrow" (D); tubular casts "red arrows", vacuolar and hydropic degeneration of tubular cells "black arrowhead"; tubular hemorrhage "black arrow" (E); and a bright greenish yellow fluorescence at the sites of immune complex deposition (F). Figures (G and H) represent splenic sections and show moderate to severe splenic congestion in red pulp "red arrow", white pulp atrophy "black arrow" (G), and peri-vascular amyloid deposits "yellow arrowheads" (H) (H&E: A–E, G, I; IF anti- IgG: F; Congo red: H) (Sharaf et al. 2023a)
In another study performed on severely affected mangy Iberian ibex, authors reported that the most prominent histological findings in the non-dermal tissues were lymphoid hyperplasia, congestion, and presence of amyloid deposits. Additionally, a wide variety of bacterial agents were isolated from lung, liver, spleen, and kidney, indicating a state of septicemia (Espinosa et al. 2017). Interestingly, Valldeperes et al. (2021) reported that no significant changes were observed in sections taken from the heart, kidney, spleen, brain, liver, skeletal muscles, and tonsils obtained from a mangy wild boar. It appears that pathological changes reported in the non-dermal tissues possibly occur only in severe forms of sarcoptic mange (Abdelaziz et al. 2022).
Complications
The primary scabetic lesions that have been eroded and excoriated by scratching result in reduced skin barrier function and secondary bacterial infection, commonly Staphylococcus aureus and group A Streptococcus (GAS) (Tasani et al. 2016). Secondary infection with Staphylococcus aureus may lead to superficial acute impetiginization, abscesses, cellulitis, echthyma, paronychia, and furunculosis. The most prevalent symptoms of superficial impetiginization are golden purulent/serous crusting or flaccid pustulation. Furthermore, it can also cause osteomyelitis, endocarditis, and potentially fatal bacterial sepsis. Screening for methicillin-resistant Staphylococcus aureus (MRSA) and choosing proper medications are crucial for better management of cases (Romani et al. 2015b; Yeoh et al. 2016; Lima et al. 2017; Engelman and Steer 2018).
Secondary bacterial infection caused by GAS can result in acute local skin and soft tissue infections ranging from superficial pyoderma, skin abscesses, and cellulitis to more severe necrotizing fasciitis. Following secondary skin infections, some patients may develop complications such as acute post-streptococcal glomerulonephritis (APSGN) and acute rheumatic fever (ARF), which are associated with chronic renal impairment and chronic rheumatic heart disease, respectively (Carapetis et al. 2005; Steer et al. 2009; Cox et al. 2021). Although GAS pharyngitis was traditionally thought to be the only source of ARF, GAS impetigo has been reported to have a role in ARF (Bowen et al. 2015; Romani et al. 2015a).
According to Sharaf et al. (2023a), scabies could act like a systemic syndrome that may affect other organs beyond the skin. Such syndrome is more likely to occur in severe cases of scabies. According to the authors, it appears that mite’s antigens and the secondary bacterial agents could induce different immune responses and inflammatory reactions, with subsequent alteration of the redox status in the affected host. The resulting oxidative stress condition could induce damage in different tissues, with subsequent changes in systemic serum biochemical and immunological parameters.
Scabies has also psychosocial implications. Since scabies induce severe itching, it can also affect sleep and quality of life of the patient. Scabies places a significant financial burden on low-income families owing to the cost of treatment, school absenteeism, and missed workdays. Hence, limiting their capacity to care for their families and offer educational opportunities for their children (Steer et al. 2009; Engelman et al. 2013; Walker et al. 2017). Furthermore, continuous itching might disrupt a child's sleep, resulting in daytime fatigue, impaired concentration, and decreased productivity (Leung et al. 2020).
Scabies can be stigmatizing for children and their caregivers since it is closely related with poverty and overcrowding and is viewed as a disease of disadvantage and poor hygiene (Jin-gang et al. 2010; Mitjà et al. 2017). Breaking down community misperceptions is still an ongoing issue (Steer et al. 2009; Romani et al. 2015b).
Conclusions
The host–parasite interaction in scabies is highly complex and involves different mechanisms, some of which are yet largely unknown. Elucidation of the nature of such interaction as well as the underlying mechanisms could allow a better understanding of the mite’s biology and the development of novel diagnostic and therapeutic options for scabies control programs. Moreover, identification of the molecular basis of such interaction could unveil novel targets for acaricidal agents and vaccines.
Availability of data and materials
Not applicable.
Abbreviations
- APSGN :
-
Acute post-streptococcal glomerulonephritis
- ARF :
-
Acute rheumatic fever
- CS :
-
Crusted scabies
- GAS :
-
Group A Streptococcus
- IFN-γ :
-
Interferon gamma
- IL :
-
Interleukin
- LCs :
-
Langerhans cells
- MRSA :
-
Methicillin-resistant Staphylococcus aureus
- OS :
-
Ordinary scabies
- S :
-
Sarcoptes
- TGF-β :
-
Transforming growth factor beta
- TNF-α :
-
Tumor necrosis factor alpha.
References
Abd El-Aal AA, Hassan MA, Gawdat HI, Ali MA, Barakat M (2016) Immunomodulatory impression of anti and proinflammatory cytokines in relation to humoral immunity in human scabies. Int J Immunopathol Pharmacol 29(2):188–194
Abdelaziz E, Elbahy N, El-Bahrawy A, El-Bahrawy A, ElKhatam A, AbouLaila M (2022) Prevalence, hematological, serum biochemical, histopathology, and molecular characterization of Sarcoptes scabiei in naturally infected rabbits from Minoufiya Governorate. Egypt Vet Parasitol Reg Stud Rep 36:100788
Abu Hafsa SH, Senbill H, Basyony MM, Hassan AA (2021) Amelioration of sarcoptic mange-induced oxidative stress and growth performance in ivermectin-treated growing rabbits using turmeric extract supplementation. Animals 11(10):2984–2997
Alasaad S, Rossi L, Heukelbach J, Pérez JM, Hamarsheh O, Otiende M et al (2013) The neglected navigating web of the incomprehensibly emerging and re-emerging Sarcoptes mite. Infect Genet Evol 17:253–259
Alsamarai A (2009) Frequency of scabies in Iraq: survey in dermatology clinic. J Infect Dev Ctries 3(10):789–793
Anderson KA, Strowd LC (2017) Epidemiology, diagnosis, and treatment of scabies in a dermatology office. J Am Board Fam Med 30(1):78–84
Ariza L, Walter B, Worth C, Brockmann S, Weber ML, Feldmeier H (2012) Investigation of a scabies outbreak in a kindergarten in Constance. Germany Eur J Clin Microbiol Infect Dis 32(3):373–380
Arlian LG, Morgan MS (2017) A review of Sarcoptes scabiei: Past, present and future. Parasit Vectors 10:297–319
Arlian LG, Morgan MS, Neal JS (2003) Modulation of cytokine expression in human keratinocytes and fibroblasts by extracts of scabies mites. Am J Trop Med Hyg 69(6):652–656
Arlian LG, Morgan MS, Neal JS (2004) Extracts of scabies mites (Sarcoptidae: Sarcoptes scabiei) modulate cytokine expression by human peripheral blood mononuclear cells and dendritic cells. J Med Entomol 41(1):69–73
Arlian LG, Morgan MS, Paul CC (2006) Evidence that scabies mites (Acari: Sarcoptidae) influence production of interleukin-10 and the function of T-regulatory cells (Tr1) in humans. J Med Entomol 43(2):283–287
Bandi KM, Saikumar C (2013) Sarcoptic mange: a zoonotic ectoparasitic skin disease. J Clin Diagn Res 7(1):156–157
Banzhaf CA, Themstrup L, Ring HC, Welzel J, Mogensen M, Jemec GB (2013) In vivo imaging of Sarcoptes scabiei infestation using optical coherence tomography. Case Rep Dermatol 5(2):156–162
Berger TG, Steinhoff M (2011) Pruritus in elderly patients: eruptions of senescence. Semin Cutan Med Surg 30(2):113–117
Bernigaud C, Samarawickrama GR, Jones MK, Gasser RB, Fischer K (2019) The challenge of developing a single-dose treatment for scabies. Trends Parasitol 35(11):931–943
Bhat SA, Mounsey KE, Liu X, Walton SF (2017) Host immune responses to the itch mite, Sarcoptes scabiei, in humans. Parasit Vectors 10(1):385–397
Bhat SA, Walton SF, Ventura T, Liu X, McCarthy JS, Burgess STG et al (2020) Early immune suppression leads to uncontrolled mite proliferation and potent host inflammatory responses in a porcine model of crusted versus ordinary scabies. PLoS Negl Trop Dis 14(9):e0008601
Bickers DR, Athar M (2006) Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 126(12):2565–2575
Boralevi F, Diallo A, Miquel J, Guerin-Moreau M, Bessis D, Chiavérini C et al (2014) Clinical phenotype of scabies by age. Pediatrics 133(4):e910–e916
Bornstein S., Mörner T., and Samuel W.M. (2001): Sarcoptes scabiei and sarcoptic mange. In: Samuel W.M., Pybus M.J., and Kocan A.A. (eds). Parasitic Diseases of Wild Mammals, 2nd ed., 107–119. Manson Publishing/The Veterinary Press, London, UK.
Bowen AC, Mahé A, Hay RJ, Andrews RM, Steer AC, Tong SY et al (2015) The Global epidemiology of impetigo: A systematic review of the population prevalence of impetigo and pyoderma. PLoS ONE 10(8):e0136789
Brook I (2002) Secondary bacterial infections complicating skin lesions. J Med Microbiol 51(10):808–812
Cai Y, Xue F, Quan C, Qu M, Liu N, Zhang Y et al (2019) A critical role of the IL-1β-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis. J Invest Dermatol 139(1):146–156
Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5(11):685–694
Cardoso JC, Veraitch O, Gianotti R, Ferrara G, Tomasini CF, Singh M et al (2017) ‘Hints’ in the horn: diagnostic clues in the stratum corneum. J Cutan Pathol 44:256–278
Cassell JA, Middleton J, Nalabanda A, Lanza S, Head MG, Bostock J et al (2018) Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes. Lancet Infect Dis 18(8):894–902
Cox V, Fuller LC, Engelman D, Steer A, Hay RJ (2021) Estimating the global burden of scabies: what else do we need? Br J Dermatol 184(2):237–242
Davis JS, McGloughlin S, Tong SY, Walton SF, Currie BJ (2013) A novel clinical grading scale to guide the management of crusted scabies. PLoS Negl Trop Dis 7(9):e2387
Doukas D, Liakou Z, Tontis D (2021) Sarcoptes scabiei dermatitis in adult sheep: an immunohistochemical study of 34 chronic cases with extensive lesions. J Hell Vet Medical Soc 72(1):2755–2764
Elder BL, Arlian LG, Morgan MS (2006) Sarcoptes scabiei (Acari: Sarcoptidae) mite extract modulates expression of cytokines and adhesion molecules by human dermal microvascular endothelial cells. J Med Entomol 43(5):910–915
Elder BL, Arlian LG, Morgan MS (2009) Modulation of human dermal microvascular endothelial cells by Sarcoptes scabiei in combination with proinflammatory cytokines, histamine, and lipid-derived biologic mediators. Cytokine 47(2):103–111
El-Moamly AA (2021) Scabies as a part of the World Health Organization roadmap for neglected tropical diseases 2021–2030: what we know and what we need to do for global control. Trop Med Health 49(1):64–75
Elwood H, Berry RS, Gardner JM, Shalin SC (2015) Superficial fibrin thrombi and other findings: a review of the histopathology of human scabietic infections. J Cutan Pathol 42(5):346–352
Engelman D, Steer AC (2018) Control strategies for scabies. Trop Med Infect Dis 3(3):98–108
Engelman D, Kiang K, Chosidow O, McCarthy J, Fuller C, Lammie P et al (2013) Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis 7(8):e2167
Engelman D, Yoshizumi J, Hay RJ, Osti M, Micali G, Norton S et al (2020) The 2020 international alliance for the control of scabies consensus criteria for the diagnosis of scabies. Br J Dermatol 183(5):808–820
Eshagh K, DeKlotz CM, Friedlander SF (2014) Infant with a papular eruption localized to the back. JAMA Pediatr 168(4):379–380
Espinosa J., Ráez-Bravo A., López-Olvera J.R., Pérez J.M., Lavín S., Tvarijonaviciute A., et al. (2017): Histopathology, microbiology and the inflammatory process associated with Sarcoptes scabiei infection in the Iberian ibex, Capra pyrenaica. Parasit. Vectors. 4;10(1):596–607.
Gazi U, Taylan-Ozkan A, Mumcuoglu KY (2022) Immune mechanisms in human Sarcoptes scabiei (Acari: Sarcoptidae) infestations. Parasite Immunol 44(1–2):e12900
Gonzalez-Lombana C, Gimblet C, Bacellar O, Oliveira WW, Passos S, Carvalho LP et al (2013) IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection. PLoS Pathog 9(3):e1003243
Hashim KO, Shafiq MAA, Al-Abassi HM, Mahmood MM (2020) Evaluation of the immune response in scabies patient (ordinary and prisoners) treated with permethrin 5%. Med Legal Update 20(3):1185–1191
Hay RJ, Steer AC, Engelman D, Walton S (2012) Scabies in the developing world: its prevalence, complications, and management. Clin Microbiol Infect 18(4):313–323
Hengge UR, Currie BJ, Jager G, Lupi O, Schwartz RA (2006) Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis 6(12):769–779
Herwanto N, Mappamasing H, Widiantari S, Indranarum T, Hidayati AN, Sawitri S et al (2019) Scabies incognito. Dermatol Reports 11(s1):157–159
Heukelbach J, Walton SF, Feldmeier H (2005) Ectoparasitic Infestations. Curr Infect Dis Rep 7(5):373–380
Heukelbach J, Mazigo HD, Ugbomoiko US (2013) Impact of scabies in resource-poor communities. Curr Opin Infect Dis 26(2):127–132
Hicks MI, Elston DM (2009) Scabies. Dermatol Ther 22(4):279–292
Hill TA, Cohen B (2017) Scabies in babies. Pediatr Dermatol 34(6):690–694
Jacobsen EA, Taranova AG, Lee NA, Lee JJ (2007) Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol 119(6):1313–1320
Jayaraj R, Hales B, Viberg L, Pizzuto S, Holt D, Rolland JM et al (2011) A diagnostic test for scabies: IgE specificity for a recombinant allergen of Sarcoptes scabiei. Diagn Microbiol Infect Dis 71(4):403–407
Jin-gang A, Sheng-xiang X, Sheng-bin X, Jun-min W, Song-mei G, Ying-ying D et al (2010) Quality of life of patients with scabies. J Eur Acad Dermatol Venereol 24(10):1187–1191
Karimkhani C, Colombara DV, Drucker AM, Norton SA, Hay R et al (2015) The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015. Lancet Infect Dis 17(12):1247–1254
Karthikeyan K (2007) Scabies in children. Arch Dis Child Educ Pract Ed 92(3):65–69
Kemp DJ, Walton SF, Harumal P, Currie BJ (2002) The scourge of scabies. Biologist 49(1):19–24
Kim H, Hashimoto T, Fischer K, Bernigaud C, Chosidow O, Yosipovitch G (2021) Scabies itch: an update on neuroimmune interactions and novel targets. J Eur Acad Dermatol Venereol 35(9):1765–1776
Klompen H (1992) Phylogenetic relationships in the mite family Sarcoptidae (Acari: Astigmata). Misc Publ Univ Mich Mus Zool 180:1–155
Kokubu H, Takahashi T, Tateishi C, Tsuruta D, Hashimoto T, Tanaka T et al (2019) Serological investigation of bullous scabies and review of the published work. J Dermatol 46(9):324–325
Kraabol M, Gundersen V, Fangel K, Olstad K (2015) The taxonomy, life cycle and pathology of Sarcoptes scabiei and Notoedres cati (Acarina, Sarcoptidae): A review in a Fennoscandian wildlife perspective. Fauna Norvegica 35:21–33
Last O, Reckhow J, Bogen B, and Rozenblat M (2018) Subungual and ungual scabies: avoiding severe presentation in high-risk patients. BMJ Case Rep 11(1):bcr2018225623
Lavery MJ, Stull C, Kinney MO, Yosipovitch G (2016) Nocturnal pruritus: The battle for a peaceful night’s sleep. Int J Mol Sci 17(3):425–437
Leung A, Lam JM, Leong KF (2020) Scabies: A neglected global disease. Curr Ped Rev 16(1):33–42
Lima FCDR, Cerqueira AMM, Guimarães MBS, Padilha CBS, Craide FH, Bombardelli M (2017) Crusted scabies due to indiscriminate use of glucocorticoid therapy in infant. An Bras Dermatol 92(3):383–385
Liu X, Walton SF, Murray HC, King M, Kelly A, Holt DC et al (2014) Crusted scabies is associated with increased IL-17 secretion by skin T cells. Parasite Immunol 36(11):594–604
Liu J, Wang H, Chang F, Liu Y, Chiu F, Lin Y et al (2016) The effects of climate factors on scabies. A 14-year population-based study in Taiwan. Parasite 23:54–61
Luo DQ, Huang MX, Liu JH, Tang W, Zhao YK, Sarkar R (2016) Bullous Scabies. Am J Trop Med Hyg 95(3):689–693
Makigami K, Ohtaki N, Yasumura SA (2012) 35-month prospective study on onset of scabies in a psychiatric hospital: discussion on patient transfer and incubation period. J Dermatol 39(2):160–163
Mathison BA, Pritt BS (2014) Laboratory identification of arthropod ectoparasites. Clin Microbiol Rev 27(1):48–67
McCarthy JS, Kemp DJ, Walton SF, Currie BJ (2004) Scabies: more than just an irritation. Postgrad Med J 80(945):382–387
Micali G, Lacarrubba F, Verzì AE, Chosidow O, Schwartz RA (2016) Scabies: Advances in noninvasive diagnosis. PLoS Negl Trop Dis 10(6):e0004691
Mika A, Reynolds SL, Mohlin FC, Willis C, Swe PM, Pickering DA et al (2012a) Novel scabies mite serpins inhibit the three pathways of the human complement system. PLoS ONE 7(7):e40489
Mika A, Reynolds SL, Pickering D, McMillan D, Sriprakash KS, Kemp D.j, et al (2012b) Complement inhibitors from scabies mites promote streptococcal growth–a novel mechanism in infected epidermis? PLoS Negl Trop Dis 6(7):e1563
Misery L (2014) Pruritus: considerable progress in pathophysiology. Med Sci 30(12):1123–1128
Mitjà O, Marks M, Bertran L, Kollie K, Argaw D, Fahal AH et al (2017) Integrated control and management of neglected tropical skin diseases. PLoS Negl Trop Dis 11(1):e0005136
Morgan MS, Arlian LG (2010) Response of human skin equivalents to Sarcoptes scabiei. J Med Entomol 47(5):877–883
Morgan MS, Arlian LG, Markey MP (2013) Sarcoptes scabiei mites modulate gene expression in human skin equivalents. PLoS ONE 8(8):e71143
Mullins JS, Arlian LG, Morgan MS (2009) Extracts of Sarcoptes scabiei de Geer downmodulate secretion of IL-8 by skin keratinocytes and fibroblasts and of GM-CSF by fibroblasts in the presence of proinflammatory cytokines. J Med Entomol 46(4):845–851
Nagase H, Okugawa S, Ota Y, Yamaguchi M, Tomizawa H, Matsushima K et al (2003) Expression and function of toll-like receptors in eosinophils: activation by toll-like receptor 7 ligand. J Immunol 171(8):3977–3982
Pence DB, Ueckermann E (2002) Sarcoptic manage in wildlife. Rev Sci Tech off Int Epiz 21(2):385–398
Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V et al (2017) Oxidative stress: Harms and benefits for human health. Oxid Med Cell Longev 2017:8416763
Prussin C, Metcalfe DD (2006) IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 117(2):450–456
Rapp CM, Morgan MS, Arlian LG (2006) Presence of host immunoglobulin in the gut of Sarcoptes scabiei (Acari: Sarcoptidae). J Med Entomol 43(3):539–542
Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11(9):785–797
Roberts LJ, Huffam SE, Walton SF, Currie BJ (2005) Crusted scabies: Clinical and immunological findings in seventy-eight patients and a review of the literature. J Inf Secur 50(5):375–381
Romani L, Koroivueta J, Steer AC, Kama M, Kaldor JM, Wand H et al (2015a) Scabies and impetigo prevalence and risk factors in Fiji: a national survey. PLoS Negl Trop Dis 9(3):e0003452
Romani L, Steer AC, Whitfeld MJ, Kaldor JM (2015b) Prevalence of scabies and impetigo worldwide: a systematic review. Lancet Infect Dis 15(8):960–967
Salame N, Holland V (2019) Non-pruritic bullous scabies in an immunosuppressed pediatric patient. Pediatr Dermatol 36(4):552–553
Schoch CL, Ciufo S, Domrachev M, Hotton CL, Kannan S, Khovanskaya R, et al. (2020) NCBI Taxonomy: a comprehensive update on curation, resources and tools. Database (Oxford). 2020: baaa062. Accessed at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408187/ on 24 January 2024
Schroeder JT (2011) Basophils: emerging roles in the pathogenesis of allergic disease. Immunol Rev 242(1):144–160
Scott-Taylor TH, Axinia SC, Amin S, Pettengell R (2018) Immunoglobulin G; structure and functional implications of different subclass modifications in initiation and resolution of allergy. Immun Inflamm Dis 6(1):13–33
Sharaf MS, Othman AA, Abd El Ghaffar AE, Ali DM, Eid MM (2023a) Crusted scabies in a rabbit model: a severe skin disease or more? Parasit Vectors 16(1):413. https://doi.org/10.1186/s13071-023-05995-8
Sharaf MS, Othman AA, Abd El Ghaffar AE, Ali DM, Eid MM (2023b) Evaluation of the scabicidal effect of a single dose of fluralaner in a rabbit model of crusted scabies. Parasitol Res 122(11):2477–2490
Sil A, Mondal S, Bhanja DB, Datta M, Mukherjee GS, Chakraborty S (2020) Pruritic Genital Nodules Pediatr Neonatol 61(2):243–244
Steer AC, Jenney AW, Kado J, Batzloff MR, La Vincente S, Waqatakirewa L et al (2009) High burden of impetigo and scabies in a tropical country. PLoS Negl Trop Dis 3(6):e467–e474
Suh KS, Han SH, Lee KH, Park JB, Jung SM et al (2014) Mites and burrows are frequently found in nodular scabies by dermoscopy and histopathology. J Am Acad Dermatol 71(5):1022–1023
Takano K, de Hayr L, Carver S, Harvey RJ, Mounsey KE (2023) Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife. Int J Parasitol Drugs Drug Resist 21:97–113
Tasani M, Tong SY, Andrews RM, Holt DC, Currie BJ, Carapetis JR et al (2016) The importance of scabies coinfection in the treatment considerations for impetigo. Ped Infect Dis J 35(4):374–378
Taves S, Ji RR (2015) Itch control by Toll-like receptors. Handb Exp Pharmacol 226:135–150
Valldeperes M, Moroni B, Rossi L, López-Olvera JR, Velarde R, Min AR et al (2021) First report of interspecific transmission of sarcoptic mange from Iberian ibex to wild boar. Parasit Vectors 14:481–494
Walker SL, Lebas E, De Sario V, Deyasso Z, Doni SN, Marks M et al (2017) The prevalence and association with health-related quality of life of tungiasis and scabies in school children in southern Ethiopia. PLoS Negl Trop Dis 11(8):e0005808
Walton SF (2010) The immunology of susceptibility and resistance to scabies. Parasite Immunol 32(8):532–540
Walton SF, Currie BJ (2007) Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev 20(2):268–279
Walton SF, Oprescu FI (2013) Immunology of scabies and translational outcomes: identifying the missing links. Curr Opin Infect Dis 26(2):116–122
Walton SF, Beroukas D, Roberts-Thomson P, Currie BJ (2008) New insights into disease pathogenesis in crusted (Norwegian) scabies: the skin immune response in crusted scabies. Br J Dermatol 158(6):1247–1255
Walton SF, Pizzutto S, Slender A, Viberg L, Holt D, Hales BJ et al (2010) Increased allergic immune response to Sarcoptes scabiei antigens in crusted versus ordinary scabies. Clin Vaccine Immunol 17(9):1428–1438
World Health Organization (2020): Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030. Geneva: World Health Organization. Available at: Available at: https://www.who.int/publications/i/item/9789240010352. Accessed 6 Jun 2023
Yalew ST (2020) Hypersensitivity reaction: Review. Int J Vet Sci Technol 4(1):028–032
Yeoh DK, Bowen AC, Carapetis JR (2016) Impetigo and scabies - Disease burden and modern treatment strategies. J Infect 72:S61–S67
Yoshinaga E, Oiso N, Kawara S, Kawada A (2009) An adolescent patient with scabies mimicking gottron papules. Case Rep Dermatol 2(1):8–12
Zhu Z, Zheng T, Homer RJ, Kim YK, Chen NY, Cohn L et al (2004) Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304(5677):1678–1682
Funding
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).
Author information
Authors and Affiliations
Contributions
The manuscript was written and revised by Mahmoud S. Sharaf.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Consent to participate and consent to publish
Not applicable.
Competing interests
The author states that there is no conflict of interest.
Additional information
Handling Editor: Julia Walochnik
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sharaf, M.S. Scabies: Immunopathogenesis and pathological changes. Parasitol Res 123, 149 (2024). https://doi.org/10.1007/s00436-024-08173-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00436-024-08173-6